23 November 2017
News and Views
Links and Services
Antiviral therapy for Hepatitis B-related liver cancer prevention is more cost-effective than cancer screening, finds the most recent issue of the Journal of Hepatology.
In Australia, Asian-born populations are 6–12 times more likely to develop hepatocellular cancer
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors